BioLife 解决方案 BLFS
$0.00 +$0.00 (0.00%)
休市 · Oct 22, 12:40 am ET
开盘$0.00
昨收$0.00
当日区间$0.00 – $0.00
成交量0.00
市值$1.89B
市盈率（TTM）32.7
股息率–
财报
财报日平均波动±10.7%近16次财报
收涨次数10 / 1663% 的概率
最佳反应+42.8%
最差反应-28.7%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q1 | 7 May 2026 | After Market | ±22.7% | -4.67% | 符合区间 |
| 2025/Q4 | 26 Feb 2026 | After Market | ±23.1% | +7.65% | 符合区间 |
| 2025/Q3 | 6 Nov 2025 | After Market | ±22.3% | -4.03% | 符合区间 |
| 2025/Q2 | 7 Aug 2025 | After Market | ±18.6% | +9.88% | 符合区间 |
| 2025/Q1 | 8 May 2025 | After Market | ±15.2% | +4.16% | 符合区间 |
| 2024/Q4 | 3 Mar 2025 | Pre Market | ±24.5% | +2.13% | 符合区间 |
| 2024/Q3 | 12 Nov 2024 | After Market | ±13.6% | -9.02% | 符合区间 |
| 2024/Q2 | 8 Aug 2024 | After Market | ±14.2% | +11.04% | 符合区间 |
| 2024/Q1 | 9 May 2024 | After Market | ±14.3% | +8.50% | 符合区间 |
| 2023/Q4 | 29 Feb 2024 | After Market | ±15.6% | +6.33% | 符合区间 |
| 2023/Q3 | 9 Nov 2023 | None | ±14.3% | -3.86% | 符合区间 |
| 2023/Q2 | 8 Aug 2023 | After Market | ±10.7% | -28.71% | 超出定价预期 |
| 2023/Q1 | 10 May 2023 | After Market | ±21.0% | -1.93% | 符合区间 |
| 2022/Q4 | 16 Mar 2023 | After Market | ±19.7% | +7.71% | 符合区间 |
| 2022/Q3 | 9 Nov 2022 | After Market | ±15.0% | +42.77% | 超出定价预期 |
| 2022/Q2 | 9 Aug 2022 | After Market | ±18.0% | +18.77% | 超出定价预期 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$28.47M+21.5% YoY
营业利润$1.70M+110.5% YoY
净利润$45.10M+384.8% YoY
摊薄每股收益$0.91+375.8% YoY
自由现金流$5.19M-7.8% YoY
经营现金流$6.35M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率63.6%
营业利润率1.6%
净利率54.3%
净资产收益率15.1%
资产收益率13.9%
投入资本回报率14.4%
流动比率9.69
负债/资产比率6.1%
现金及投资$82.42M
总负债$13.15M
净现金（净负债）$69.27M
暂无评论——快来第一个聊聊 BLFS。
登录后参与讨论。